Lipids in Pulmonary Drug Delivery
Editat de Md Faiyazuddin, Hasan Ali, Md Akbar, Babar Iqbalen Limba Engleză Paperback – 28 feb 2025
In addition, the authors include an update on the clinical status of the potential lipid nanocarriers used for effective management of the pulmonary related diseases. Written in a technical way covering the latest advancements in lipid-based drug delivery for pulmonary administration, this book is a useful reference for researchers, scientists, and graduate and postgraduate students working on, or planning, research in the field of lipid-based nano-drug pulmonary delivery platforms.
- Presents unique and comprehensive information on lipid-based nanomedicines for pulmonary drug delivery
- Provides insights into the biological fate and interplay of nanoparticles with the environment of the pulmonary system
- Acts as a guide for the future applications of lipid-based nanomedicine in the clinical setting for the precise management of pulmonary diseases
Preț: 860.31 lei
Preț vechi: 1080.83 lei
-20% Nou
Puncte Express: 1290
Preț estimativ în valută:
164.62€ • 179.38$ • 138.72£
164.62€ • 179.38$ • 138.72£
Carte disponibilă
Livrare economică 26 martie-09 aprilie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780443223747
ISBN-10: 0443223742
Pagini: 544
Dimensiuni: 191 x 235 mm
Greutate: 0.45 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 0443223742
Pagini: 544
Dimensiuni: 191 x 235 mm
Greutate: 0.45 kg
Editura: ELSEVIER SCIENCE
Cuprins
- Lipid Nanotechnology
- Current Scenario and Challenges of Lipid-Based Nanomedicines for Pulmonary Drug Delivery
- Effect of Environment of the Respiratory Tract on Nanomedicine Drug Delivery
- Aerodynamics and Deposition of Lipid-Based Nanocarriers in Lungs
- Liposome as a Versatile Carrier for Pulmonary Drug Delivery
- Advancements in Nano-Structured Lipid Carrier (NLCs) as Drug Delivery Vehicle in Lungs
- Solid Lipid Nanoparticles: A Potential Drug Carrier in Pulmonary System
- Insights and Applications of Nanoemulsions as a Drug Carrier in Lungs
- Lipid-Based Drug Delivery for Lung Cancer
- Exploring the State-of-Art of Lipid Nanomedicines for Obstructive Pulmonary Diseases
- Lipid-Based Drug Delivery for Pulmonary Microbial Infections
- Lipid-Based Drug Delivery for Systemic Effect Through Pulmonary Route of Administration
- Biofate of Lipid-Based Nanomedicine After Pulmonary Administration
- Surface Modification of Lipid-Based Drug Delivery for Lungs
- Evaluation of Lipid-Based Formulation for Pulmonary Delivery
- Physico-Chemical Stability of Lipid-Based Nanocarriers in Aerosol Formulation
- Translation of Lipid-Based Formulation for Pulmonary Drug Delivery System: Clinical Status
- Regulatory Aspects of Lipid-Based Nanomedicine for Pulmonary Applications
- Lipid-Based Vaccines Against Viruses Including COVID-19
- Lipid-Based Nanocarriers in the Management of Cystic Fibrosis: A Pulmonary Complication
- Pulmonary Drug Delivery of Lipid-Based Formulations via Nebulizers
- Lipid-Based Peptide and Gene Delivery to Lungs